» Articles » PMID: 38862973

Adipocyte Pyroptosis Occurs in Omental Tumor Microenvironment and is Associated with Chemoresistance of Ovarian Cancer

Overview
Journal J Biomed Sci
Publisher Biomed Central
Specialty Biology
Date 2024 Jun 11
PMID 38862973
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ovarian carcinoma (OC) is a fatal malignancy, with most patients experiencing recurrence and resistance to chemotherapy. In contrast to hematogenous metastasizing tumors, ovarian cancer cells disseminate within the peritoneal cavity, especially the omentum. Previously, we reported omental crown-like structure (CLS) number is associated with poor prognosis of advanced-stage OC. CLS that have pathologic features of a dead or dying adipocyte was surrounded by several macrophages is well known a histologic hallmark for inflammatory adipose tissue. In this study, we attempted to clarify the interaction between metastatic ovarian cancer cells and omental CLS, and to formulate a therapeutic strategy for advanced-stage ovarian cancer.

Methods: A three-cell (including OC cells, adipocytes and macrophages) coculture model was established to mimic the omental tumor microenvironment (TME) of ovarian cancer. Caspase-1 activity, ATP and free fatty acids (FFA) levels were detected by commercial kits. An adipocyte organoid model was established to assess macrophages migration and infiltration. In vitro and in vivo experiments were performed for functional assays and therapeutic effect evaluations. Clinical OC tissue samples were collected for immunochemistry stain and statistics analysis.

Results: In three-cell coculture model, OC cells-derived IL-6 and IL-8 could induce the occurrence of pyroptosis in omental adipocytes. The pyroptotic adipocytes release ATP to increase macrophage infiltration, release FFA into TME, uptake by OC cells to increase chemoresistance. From OC tumor samples study, we demonstrated patients with high gasdermin D (GSDMD) expression in omental adipocytes is highly correlated with chemoresistance and poor outcome in advanced-stage OC. In animal model, by pyroptosis inhibitor, DSF, effectively retarded tumor growth and prolonged mice survival.

Conclusions: Omental adipocyte pyroptosis may contribute the chemoresistance in advanced stage OC. Omental adipocytes could release FFA and ATP through the GSDMD-mediate pyroptosis to induce chemoresistance and macrophages infiltration resulting the poor prognosis in advanced-stage OC. Inhibition of adipocyte pyroptosis may be a potential therapeutic modality in advanced-stage OC with omentum metastasis.

Citing Articles

Innovative optimization of greater omentum imaging report and data system for enhanced risk stratification of omental lesions.

Chen Z, Sang L, Cheng Y, Wang X, Lv M, Liu Y Cancer Imaging. 2025; 25(1):28.

PMID: 40065469 PMC: 11892154. DOI: 10.1186/s40644-025-00848-2.


Ovarian tumor microenvironment contributes to tumor progression and chemoresistance.

Ponton-Almodovar A, Sanderson S, Rattan R, Bernard J, Horibata S Cancer Drug Resist. 2025; 7():53.

PMID: 39802952 PMC: 11724355. DOI: 10.20517/cdr.2024.111.


TIGIT CD4 regulatory T cells enhance PD-1 expression on CD8 T cells and promote tumor growth in a murine ovarian cancer model.

Chen F, Xu Y, Liu X, Dong N, Tian L J Ovarian Res. 2024; 17(1):252.

PMID: 39707532 PMC: 11660701. DOI: 10.1186/s13048-024-01578-y.

References
1.
Rotter V, Nagaev I, Smith U . Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem. 2003; 278(46):45777-84. DOI: 10.1074/jbc.M301977200. View

2.
Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao C . Pyroptosis in inflammatory diseases and cancer. Theranostics. 2022; 12(9):4310-4329. PMC: 9169370. DOI: 10.7150/thno.71086. View

3.
Wang J, Kubes P . A Reservoir of Mature Cavity Macrophages that Can Rapidly Invade Visceral Organs to Affect Tissue Repair. Cell. 2016; 165(3):668-78. DOI: 10.1016/j.cell.2016.03.009. View

4.
Ghisoni E, Imbimbo M, Zimmermann S, Valabrega G . Ovarian Cancer Immunotherapy: Turning up the Heat. Int J Mol Sci. 2019; 20(12). PMC: 6628106. DOI: 10.3390/ijms20122927. View

5.
Derosa G, Fogari E, DAngelo A, Bianchi L, Bonaventura A, Romano D . Adipocytokine levels in obese and non-obese subjects: an observational study. Inflammation. 2013; 36(4):914-20. DOI: 10.1007/s10753-013-9620-4. View